M Daben J Libardo

Years Active: 2019-2023
Publications (10 Years): 5

Merck and Co Inc West Point

University of Connecticut (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Merck and Co Inc West Point Sep 16 2019

United States

Senior Scientist :: Infectious Disease & Vaccines

Education History

University of Connecticut Aug 24 2012

United States

PHD :: Chemistry

University of the Philippines Diliman Jun 07 2007 - Apr 17 2011

Philippines

BSC :: Institute of Chemistry

Publications

M Daben J Libardo, Eberhard Durr, Lorraine D Hernandez
A Robust Protocol to Isolate Outer Membrane Vesicles from Nontypeable Haemophilus influenzae . Methods and protocols 6 (2) (2023)
M Daben J Libardo, Eberhard Durr, Lorraine D Hernandez
A Robust Protocol to Isolate Outer Membrane Vesicles from Nontypeable Haemophilus influenzae . Methods and protocols 6 (2) (2023)
M Daben J Libardo, Eberhard Durr, Lorraine D Hernandez
A Robust Protocol to Isolate Outer Membrane Vesicles from Nontypeable Haemophilus influenzae . Methods and protocols 6 (2) (2023)
Andrew J Whitehouse, Sherine E Thomas, Karen P Brown, Alexander Fanourakis, Daniel S-H Chan, M Daben J Libardo, Vitor Mendes, Helena I M Boshoff, R Andres Floto, Chris Abell, Tom L Blundell, Anthony G Coyne
Development of Inhibitors against Mycobacterium abscessus tRNA (m1G37) Methyltransferase (TrmD) Using Fragment-Based Approaches. Journal of medicinal chemistry 62 (15) (2019)
Andrew J Whitehouse, M Daben J Libardo, Monica Kasbekar, Paul D Brear, Gerhard Fischer, Craig J Thomas, Clifton E Barry, Helena I M Boshoff, Anthony G Coyne, Chris Abell
Targeting of Fumarate Hydratase from Mycobacterium tuberculosis Using Allosteric Inhibitors with a Dimeric-Binding Mode. Journal of medicinal chemistry 62 (23) (2019)

M Daben J Libardo.css-eqlu8i{font-size:small;padding-left:4px;}